Open access
Sep 2026
Real-world effectiveness and safety of secukinumab in giant cell arteritis: an Italian multicentre cohort study.
In this multicentre real-world cohort of patients with GCA, including those with relapsing disease and previous biologic exposure, secukinumab was associated with high observed remission rates, progressive GC dose reduction and increasing GC-free remission.
Luca Iorio, Federica Davanzo, C. Ricordi et al.
· Arthritis care & research · 0 citations